Romosozumab shows bone mineral density gain in postmenopausal women with severe osteoporosis, irrespective of prior exposure ...

The new approvals bring the number of denosumab biosimilars in the US to eight, but price reductions are not yet substantial.

Fracture risk and treatment need careful individual assessment Osteopenia is the most common result of a bone mineral density (BMD) measurement by dual-energy x-ray absorptiometry (DXA) in older ...

These include the RANKL inhibitor denosumab (Prolia), the anabolic agents teriparatide (Forteo) and abaloparatide (Tymlos), ...

Entera Bio’s osteoporosis candidate for postmenopausal women showed statistically significant improvements in bone density in ...

Osteoporosis, known as the silent bone disease, weakens bones without obvious symptoms. Early signs include height loss, ...

As such, at ESMO 2025, the investigators analyzed patients with or without baseline bone metastases treated with lenvatinib + pembrolizumab versus sunitinib in the CLEAR study with ∼4 years follow-up ...

You may take magnesium and potassium supplements together to correct deficiencies or for other reasons. The two minerals work together to support health.

For most breast cancer survivors, the battle doesn’t end with remission. While the focus often remains on keeping the cancer ...